Loading organizations...
§ Private Profile · London
MPowder is a technology company.
MPowder develops plant-based nutritional supplements tailored for women experiencing perimenopause, menopause, and postmenopause. Its product line, including specialized blends like PERI-BOOST and MENO-BOOST, targets hormone health and overall well-being. The company integrates naturopathic principles with scientific research, formulating offerings to holistically address symptoms and support women through midlife transitions.
Rebekah Brown founded MPowder after her personal challenging experience with perimenopause at age 45. Her insight stemmed from the systemic neglect of female biology, underfunded research, and societal dismissal of midlife health. Brown established MPowder to create an evidence-based solution for women seeking support during this critical stage.
MPowder serves women navigating various stages of menopause, providing nutritional products, a supportive community, and resources. The company's vision extends beyond supplements, aiming to empower women to understand their changing bodies, reclaim agency over their health, and redefine midlife. This mission is realized through co-creation, community, and open conversation.
MPowder has raised $660K across 1 funding round.
MPowder has raised $660K in total across 1 funding round.
MPowder is a women's health supplement brand focused on hormone health and midlife wellness, blending naturopathy with modern science. It offers award-winning supplement blends for whole-body support, targeting women navigating midlife transitions like menopause. The company serves women frustrated with undervalued female biology in traditional healthcare, partnering exclusively with hand-selected US multidisciplinary clinics for wraparound care including tele-coaching. MPowder solves problems of underfunded research and siloed treatments by funding its own Product Insight Studies, refining products based on feedback from over 40,000 voices, and fostering a community-driven movement for empowered midlife health[2].
MPowder emerged from founders' frustration with systemic neglect of female biology, underfunded research, and midlife viewed as decline rather than opportunity. Developed over four years in partnership with over 40,000 women, it combines mother nature's wisdom with scientific backing and naturopathic roots. Pivotal early traction came from real-world results and collaborations, evolving into an award-winning range that emphasizes lived experience over silver-bullet solutions[2].
MPowder rides the wave of personalized women's health tech and wellness, capitalizing on rising demand for hormone-focused solutions amid menopause awareness (e.g., growing telehealth and DTC supplements). Timing aligns with post-pandemic shifts toward holistic, community-based care and naturopathy integration with science, fueled by market forces like underinvestment in female biology research. It influences the ecosystem by pioneering clinic partnerships for wraparound services, funding studies to bridge research gaps, and normalizing midlife as a "superpower" phase, potentially accelerating DTC health brands with social impact[2].
MPowder is poised to expand its movement through deeper clinic integrations, more self-funded research, and global scaling beyond US partners, as women's health funding surges. Trends like AI-personalized supplements and menopause mainstreaming will amplify its momentum, evolving it from supplement brand to full ecosystem leader. This positions MPowder to redefine midlife not as decline, but as the empowered beginning its origin story promised[2].
MPowder has raised $660K across 1 funding round. Most recently, it raised $660K Seed in November 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 1, 2020 | $660K Seed | — | Pink Salt Ventures, Carrie Longton, Founders Factory | Announced |
MPowder has raised $660K in total across 1 funding round.
MPowder's investors include Pink Salt Ventures, Carrie Longton, Founders Factory.